Psoriasis
Anti-IL-23 Monoclonal Antibodies for Psoriasis
Biologics have become a well-established treatment for psoriasis, especially in those patients with moderate to severe plaque psoriasis who cannot be controlled on topical ...
Hidradenitis Suppurativa, Skin Conditions
HUMIRA (adalimumab) Approved for Hidradinitis Supparitiva
Recently the biologic HUMIRA (adalimumab) was approved by the FDA for the treatment of moderate to severe hidradenitis supparativa (HS), an often debilitating disease ...